MURIANNI, VERONICA
 Distribuzione geografica
Continente #
EU - Europa 609
AS - Asia 45
SA - Sud America 9
NA - Nord America 5
AF - Africa 1
Totale 669
Nazione #
IT - Italia 606
SG - Singapore 21
CN - Cina 12
VN - Vietnam 10
BR - Brasile 7
CO - Colombia 2
MX - Messico 2
US - Stati Uniti d'America 2
DK - Danimarca 1
DO - Repubblica Dominicana 1
FI - Finlandia 1
ID - Indonesia 1
IQ - Iraq 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 669
Città #
Genoa 421
Rapallo 74
Vado Ligure 66
Genova 44
Ho Chi Minh City 6
Beijing 5
São Paulo 3
Singapore 2
Ashburn 1
Basra 1
Bedsted Thy 1
Biên Hòa 1
Bordighera 1
Guadalupe 1
Guangzhou 1
Guarulhos 1
Haiphong 1
Helena 1
Itapevi 1
Iztapalapa 1
Johannesburg 1
Lappeenranta 1
Ljubljana 1
Maceió 1
Osasco 1
Pasto 1
Phủ Lý 1
Santa Marta 1
Santiago de los Caballeros 1
Thái Nguyên 1
Totale 643
Nome #
802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study 130
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib 95
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study) 86
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study 79
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study) 78
1476P Immunohistochemical (mIHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: Main results from the Meet-URO 18 study 75
Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case report 58
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study 50
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9) 42
Totale 693
Categoria #
all - tutte 3.416
article - articoli 3.416
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 2 1 2 2 7 4
2021/202227 0 0 3 2 0 0 0 6 5 1 3 7
2022/202387 5 6 0 11 13 7 5 11 9 4 15 1
2023/202494 4 5 3 8 4 23 3 2 4 7 5 26
2024/2025232 24 11 2 10 15 22 18 54 10 8 33 25
2025/2026231 58 46 38 39 42 8 0 0 0 0 0 0
Totale 693